Key result
Liraglutide improves clinical stability over standard care in advanced HFrEF.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Supports liraglutide in advanced HFrEF management; extends GLP-1 agonist evidence to systolic heart failure.
clinicaltrials.gov Identifier: NCT01800968.
No takes yet. Share an insight, caveat, or question.
Margulies et al. (2016) studied this question. Liraglutide improved clinical stability in patients with advanced heart failure and reduced ejection fraction compared to standard care.
Synapse has enriched 10 related papers. Consider them for comparative context: